mci 9038 has been researched along with Arterial Occlusive Diseases in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 8 (50.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatakeyama, M; Munakata, M; Ono, Y | 1 |
| Accrocca, F; Antonelli, R; Gabrielli, R; Giordano, GA; Marcucci, G; Rosati, MS; Siani, A | 1 |
| Asai, Y; Doi, M; Murawaki, A; Nakashima, K; Nakayasu, H; Omura, H; Suzuki-Kinoshita, K | 1 |
| Ikoma, H | 1 |
| Bozlar, U; Simsek, S; Turba, UC | 1 |
| Kawai, H; Nakashima, M; Umemura, K | 1 |
| Ishida, H; Nakayasu, H; Nukaya, H; Tsuji, K | 2 |
| Fukazawa, T; Goto, Y; Hayashi, H; Inoue, Y; Komatsu, Y | 1 |
| Eguchi, K; Kizaki, Y; Matsumoto, K; Matsunaga, Y; Miyake, S; Tominaga, Y; Ueki, Y; Yano, M; Yoshida, K | 1 |
| Ishida, H; Nakayasu, H; Tsuji, K | 1 |
| Hayakawa, M; Matsuzawa, M; Morishima, H; Ono, H; Oshima, K; Taguchi, Y | 1 |
| Giddings, JC; Hashimoto, M; Oiwa, K; Watanabe, S; Yamamoto, J; Yamashita, T | 1 |
| Bush, LR; Connolly, TM; Mellott, MJ; York, SJ | 1 |
| Collen, D; Fallon, JT; Gold, HK; Jang, IK; Leinbach, RC; Ziskind, AA | 1 |
| Abiko, Y; Hara, T; Iwamoto, M; Kumada, T; Ogawa, H; Tomikawa, M | 1 |
2 review(s) available for mci 9038 and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Development of argatroban as an anticoagulant and antithrombin agent in Japan.
Topics: Anticoagulants; Arginine; Arterial Occlusive Diseases; Humans; Intracranial Thrombosis; Japan; Pipecolic Acids; Product Surveillance, Postmarketing; Renal Dialysis; Sulfonamides; Thrombin | 2002 |
Incarceration of the basilar artery in a longitudinal fracture of the clivus: case report and literature review.
Topics: Antithrombins; Arginine; Arterial Occlusive Diseases; Basilar Artery; Cranial Fossa, Posterior; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pipecolic Acids; Respiration, Artificial; Skull Fractures; Sulfonamides; Tomography, X-Ray Computed; Treatment Outcome | 2000 |
1 trial(s) available for mci 9038 and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Argatroban increases nitric oxide levels in patients with peripheral arterial obstructive disease: placebo-controlled study.
Topics: Aged; Anticoagulants; Arginine; Arterial Occlusive Diseases; Female; Hemoglobins; Humans; Infusions, Intravenous; Male; Microcirculation; Middle Aged; Nitric Oxide; Pipecolic Acids; Sulfonamides | 1999 |
13 other study(ies) available for mci 9038 and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Thrombosis of biatrial appendages due to heparin-induced thrombocytopenia.
Topics: Aged, 80 and over; Antibodies; Anticoagulants; Arginine; Arterial Occlusive Diseases; Atrial Appendage; Atrial Fibrillation; Biomarkers; Coronary Artery Bypass; Drug Administration Schedule; Drug Substitution; Female; Heart Diseases; Heparin; Humans; Pipecolic Acids; Sulfonamides; Thrombectomy; Thrombocytopenia; Thrombosis; Tomography, X-Ray Computed | 2013 |
Heparin-induced thrombocytopenia type II because of heparin-coated polytetrafluoroethylene graft used to bypass.
Topics: Aged; Anticoagulants; Arginine; Arterial Occlusive Diseases; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Device Removal; Early Diagnosis; Female; Heparin; Humans; Lower Extremity; Pipecolic Acids; Polytetrafluoroethylene; Prosthesis Design; Reoperation; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2011 |
Heparin-induced thrombocytopenia in essential thrombocytosis.
Topics: Aged; Anticoagulants; Arginine; Arterial Occlusive Diseases; Bone Marrow Examination; Cerebral Infarction; Constriction, Pathologic; Diagnosis, Differential; Disseminated Intravascular Coagulation; Female; Femoral Artery; Heparin; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Predictive Value of Tests; Sulfonamides; Thrombocythemia, Essential; Thrombocytopenia; Thrombophlebitis; Treatment Outcome | 2012 |
Catheter-directed thrombolysis of acute lower extremity arterial thrombosis in a patient with heparin-induced thrombocytopenia.
Topics: Aged; Anticoagulants; Arginine; Arterial Occlusive Diseases; Catheterization, Peripheral; Fibrinolytic Agents; Heparin; Humans; Infusions, Intra-Arterial; Lower Extremity; Male; Pipecolic Acids; Radiography; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome | 2007 |
Effect of argatroban on microthrombi formation and brain damage in the rat middle cerebral artery thrombosis model.
Topics: Animals; Antithrombins; Arginine; Arterial Occlusive Diseases; Cerebral Arteries; Disease Models, Animal; Intracranial Embolism and Thrombosis; Male; Pipecolic Acids; Rats; Rats, Wistar; Sulfonamides; Thrombin; Time Factors | 1995 |
Study of the pharmacological effect of the bile salt, sodium scymnol sulfate, from Rhizoprionodon acutus. II. Prophylactic effect of scymnol on lesion development in a rat peripheral arterial occlusion model.
Topics: Animals; Antithrombins; Arginine; Arterial Occlusive Diseases; Blood Coagulation; Cholestanols; Elasmobranchii; Fibrinolysis; Male; Pipecolic Acids; Rats; Rats, Wistar; Sulfonamides; Ticlopidine | 1998 |
Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
Topics: Amino Acid Sequence; Animals; Arginine; Arterial Occlusive Diseases; Arteriovenous Shunt, Surgical; Chlorides; Drug Evaluation, Preclinical; Ferric Compounds; Fibrinolytic Agents; Glass; Hemorrhage; Heparin; Hirudin Therapy; Hirudins; Molecular Sequence Data; Pipecolic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Serine Proteinase Inhibitors; Sulfonamides; Thrombin; Thrombosis; Vena Cava, Inferior; Venous Thrombosis | 1999 |
Study of the pharmacological effect of the bile salt, sodium scymnol sulfate, from Rhizoprionodon acutus. III. Protective effect of scymnol against vascular endothelial cell damage in a rat peripheral arterial occlusion model.
Topics: Alanine Transaminase; Animals; Antithrombin III; Arginine; Arterial Occlusive Diseases; Aspartate Aminotransferases; Bile Acids and Salts; Cells, Cultured; Cholestanols; Elasmobranchii; Endothelium, Vascular; L-Lactate Dehydrogenase; Male; Peripheral Vascular Diseases; Pipecolic Acids; Rats; Rats, Wistar; Sulfonamides; Ticlopidine | 1999 |
Study of the pharmacological effect of the bile salt, sodium scymnol sulfate, from Rhizoprionodon acutus. IV. Effects of naturally occurring bile alcohols, bile acids and their conjugates on lesion development and vascular endothelial cell injury in a rat
Topics: Animals; Arginine; Arterial Occlusive Diseases; Bile Acids and Salts; Cholestanols; Elasmobranchii; Endothelium, Vascular; Isoenzymes; L-Lactate Dehydrogenase; Male; Peripheral Vascular Diseases; Pipecolic Acids; Rats; Rats, Wistar; Sulfonamides | 1999 |
Enhancement of endogenous plasminogen activator-induced thrombolysis by argatroban and APC and its control by TAFI, measured in an arterial thrombolysis model in vivo using rat mesenteric arterioles.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Arterioles; Binding, Competitive; Carboxypeptidase B2; Enzyme Activation; Enzyme Inhibitors; Fibrinolysis; Fibrinolytic Agents; Image Processing, Computer-Assisted; Lasers; Male; Mesenteric Arteries; Models, Animal; Pipecolic Acids; Plant Proteins; Plasminogen Activators; Protease Inhibitors; Protein C; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides; Swine; Thrombosis | 2002 |
Prevention of reocclusion by MCI-9038, a thrombin inhibitor, following t-PA-induced thrombolysis in a canine model of femoral arterial thrombosis.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Disease Models, Animal; Dogs; Femoral Artery; Hemodynamics; Male; Pipecolic Acids; Recurrence; Regional Blood Flow; Sulfonamides; Thrombin; Thrombin Time; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 1990 |
Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.
Topics: Animals; Antithrombins; Arginine; Arterial Occlusive Diseases; Bleeding Time; Blood Platelets; Femoral Artery; Graft Occlusion, Vascular; Heparin; In Vitro Techniques; Injections, Intra-Arterial; Injections, Intravenous; Pipecolic Acids; Rabbits; Regional Blood Flow; Sulfonamides; Thrombosis | 1990 |
[Preventive effects of synthetic antithrombin, MD-805, on animal thrombosis models].
Topics: Acute Disease; Animals; Antithrombin III Deficiency; Antithrombins; Arginine; Arterial Occlusive Diseases; Mice; Pipecolic Acids; Pulmonary Embolism; Rats; Rats, Inbred Strains; Sulfonamides; Thrombosis; Vena Cava, Inferior | 1987 |